sb 203580 has been researched along with betadex in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 8,785 | 97 | 4,452 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blakely, RD; Carneiro, AM; Chang, JC; Piston, DW; Rosenthal, SJ; Tomlinson, ID; Ustione, A; Warnement, MR | 1 |
1 other study(ies) available for sb 203580 and betadex
| Article | Year |
|---|---|
Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation.
Topics: Actins; Animals; beta-Cyclodextrins; Cell Line, Transformed; Cholera Toxin; Cholesterol; Cyclic GMP; Cytochalasin D; Enzyme Inhibitors; Gangliosidosis, GM1; Imidazoles; Ligands; Membrane Microdomains; Microscopy, Confocal; Neurons; Normal Distribution; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Protein Transport; Pyridines; Quantum Dots; Rats; Serotonin; Serotonin Plasma Membrane Transport Proteins; Thionucleotides | 2012 |